Heffernan Michael Thomas (CIK 1448914) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-17). Recent activity: Buy TRVI (18,421 shares), Sell TRVI (18,321 shares), Sell TRVI (100 shares), Buy TRVI (21,052 shares), Sell TRVI (20,952 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Trevi Therapeutics, Inc. (TRVI) | Director | Buy | 18,421 | $56,000 |
| 2026-09-17 | Trevi Therapeutics, Inc. (TRVI) | Director | Sell | 18,321 | $276,464 |
| 2026-09-17 | Trevi Therapeutics, Inc. (TRVI) | Director | Sell | 100 | $1,588 |
| 2026-09-17 | Trevi Therapeutics, Inc. (TRVI) | Director | Buy | 21,052 | $70,103 |
| 2026-09-17 | Trevi Therapeutics, Inc. (TRVI) | Director | Sell | 20,952 | $316,166 |
| 2026-09-17 | Trevi Therapeutics, Inc. (TRVI) | Director | Sell | 100 | $1,588 |
来源：SEC Form 4 申报文件 · 截至 2026-09-17